Management of Skin Sarcomas.

[1]  A. B. Hassan,et al.  Soft tissue and visceral sarcomas: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2021, Annals of oncology : official journal of the European Society for Medical Oncology.

[2]  A. Folpe,et al.  Treatment outcome of superficial leiomyosarcoma , 2020, Journal of surgical oncology.

[3]  M. Peifer,et al.  Integrative Analysis of Pleomorphic Dermal Sarcomas Reveals Fibroblastic Differentiation and Susceptibility to Immunotherapy , 2020, Clinical Cancer Research.

[4]  A. Cesinaro,et al.  Atypical fibroxanthoma and pleomorphic dermal sarcoma: A reappraisal , 2020, Journal of cutaneous pathology.

[5]  M. Henderson,et al.  Cutaneous leiomyosarcoma: dermal and subcutaneous , 2020, The Australasian journal of dermatology.

[6]  W. V. van Houdt.  Margins in DFSP Reconsidered: Primum Non Nocere , 2019, Annals of Surgical Oncology.

[7]  J. Blay,et al.  Watch and Wait Approach for Re-excision After Unplanned Yet Macroscopically Complete Excision of Extremity and Superficial Truncal Soft Tissue Sarcoma is Safe and Does Not Affect Metastatic Risk or Amputation Rate , 2019, Annals of Surgical Oncology.

[8]  M. Council,et al.  Atypical Fibroxanthoma: The Washington University Experience. , 2019, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[9]  F. van Coevorden,et al.  Outcome after surgical treatment of dermatofibrosarcoma protuberans: Is clinical follow‐up always indicated? , 2019, Cancer.

[10]  C. Berking,et al.  Primary leiomyosarcoma of the skin: a comprehensive review on diagnosis and treatment , 2018, Medical Oncology.

[11]  F. van Coevorden,et al.  Isolated limb perfusion for locally advanced angiosarcoma in extremities: A multi-centre study. , 2017, European journal of cancer.

[12]  Teo Soleymani,et al.  Conception and Management of a Poorly Understood Spectrum of Dermatologic Neoplasms: Atypical Fibroxanthoma, Pleomorphic Dermal Sarcoma, and Undifferentiated Pleomorphic Sarcoma , 2017, Current Treatment Options in Oncology.

[13]  A. Rosenberg,et al.  Stewart-Treves Syndrome: A Case Report and Review of the Literature , 2016, Case Reports in Oncology.

[14]  P. Tan,et al.  Sarcoma of the breast: an update on a rare entity , 2016, Journal of Clinical Pathology.

[15]  J. Malvehy,et al.  Diagnosis and treatment of dermatofibrosarcoma protuberans. European consensus-based interdisciplinary guideline. , 2015, European journal of cancer.

[16]  D. Schadendorf,et al.  TERT promoter mutations are frequent in atypical fibroxanthomas and pleomorphic dermal sarcomas , 2014, Modern Pathology.

[17]  T. Mentzel.  Cutaneous mesenchymal tumours: an update. , 2014, Pathology.

[18]  J. Utikal,et al.  Neoadjuvant Imatinib in Advanced Primary or Locally Recurrent Dermatofibrosarcoma Protuberans: A Multicenter Phase II DeCOG Trial with Long-term Follow-up , 2013, Clinical Cancer Research.

[19]  T. Brenn,et al.  Pleomorphic Dermal Sarcoma: Adverse Histologic Features Predict Aggressive Behavior and Allow Distinction From Atypical Fibroxanthoma , 2012, The American journal of surgical pathology.

[20]  E. Sturgis,et al.  Outcomes after definitive treatment for cutaneous angiosarcoma of the face and scalp , 2011, Head & neck.

[21]  S. Kraft,et al.  Atypical Intradermal Smooth Muscle Neoplasms: Clinicopathologic Analysis of 84 Cases and a Reappraisal of Cutaneous “Leiomyosarcoma” , 2011, The American journal of surgical pathology.

[22]  D. Henson,et al.  Cutaneous angiosarcoma. Analysis of 434 cases from the Surveillance, Epidemiology, and End Results Program, 1973-2007. , 2011, Annals of diagnostic pathology.

[23]  P. Heenan,et al.  Atypical Fibroxanthoma: A Histological and Immunohistochemical Review of 171 Cases , 2010, The American Journal of dermatopathology.

[24]  G. Ferrara,et al.  Primary cutaneous leiomyosarcoma: clinicopathological analysis of 36 cases , 2010, Histopathology.

[25]  A. Weaver,et al.  More Than 2 Decades of Treating Atypical Fibroxanthoma at Mayo Clinic: What Have We Learned From 91 Patients? , 2009, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[26]  R. Aft,et al.  Treatment and outcomes of patients with primary breast sarcoma. , 2008, American journal of surgery.

[27]  N. Magné,et al.  Outcome and prognostic factors in breast sarcoma: a multicenter study from the rare cancer network. , 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[28]  C. Blomqvist,et al.  Clinical course of nonvisceral soft tissue leiomyosarcoma in 225 patients from the Scandinavian Sarcoma Group , 2007, Cancer.

[29]  A. Eggermont,et al.  Isolated limb perfusion with tumor necrosis factor and melphalan for nonresectable Stewart-Treves lymphangiosarcoma , 2002, Annals of Surgical Oncology.

[30]  D. Kirsch,et al.  Treatment and Outcome of 82 Patients with Angiosarcoma , 2007, Annals of Surgical Oncology.

[31]  M. Brennan,et al.  Post-treatment sarcoma in breast cancer patients , 2006, Annals of Surgical Oncology.

[32]  C. Mussi,et al.  Dermatofibrosarcoma protuberans treated at a single institution: a surgical disease with a high cure rate. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[33]  C. Reynolds,et al.  Primary breast sarcoma: clinicopathologic series from the Mayo Clinic and review of the literature , 2004, British Journal of Cancer.

[34]  V. Sondak,et al.  Cutaneous angiosarcoma of the scalp , 2003, Cancer.

[35]  J. Goldblum,et al.  Sarcomas arising in dermatofibrosarcoma protuberans: a reappraisal of biologic behavior in eighteen cases treated by wide local excision with extended clinical follow up. , 2000, The American journal of surgical pathology.

[36]  S. Grobmyer,et al.  Role of surgery in the management of postmastectomy extremity angiosarcoma (Stewart‐Treves syndrome) , 2000, Journal of surgical oncology.

[37]  C. Catton,et al.  An analysis of 78 breast sarcoma patients without distant metastases at presentation. , 2000, International journal of radiation oncology, biology, physics.

[38]  M. Ballo,et al.  The role of radiation therapy in the management of dermatofibrosarcoma protuberans. , 1998, International journal of radiation oncology, biology, physics.

[39]  H. Gutman,et al.  Sarcoma of the breast: implications for extent of therapy. The M. D. Anderson experience. , 1994, Surgery.

[40]  T. Kaufmann,et al.  Post-mastectomy lymphangiosarcoma (Stewart-Treves syndrome): report of two long-term survivals. , 1991, The British journal of radiology.

[41]  A. Auquier,et al.  Long-term risk of sarcoma following radiation treatment for breast cancer. , 1991, International journal of radiation oncology, biology, physics.

[42]  F. Stewart,et al.  Lymphangiosarcoma in postmastectomy lymphedema. A report of six cases in elephantiasis chirurgica , 1948, Cancer.

[43]  J. C. Ivins,et al.  Lymphangiosarcoma arising in chronic lymphedematous extremities , 1962, Cancer.